What are the conceptual stocks of the new crown test?

Since the outbreak of the new crown outbreak, the new crown virus detection reagents, equipment demand is also increasing. The new crown detection concept stocks have what?

New crown detection concept stock leading list

McAuliffe: medical division under the Xiamen McAuliffe Medical Laboratory Ltd. to undertake the Xiamen region part of the new crown virus nucleic acid test business; the company's subordinate Xiamen McAuliffe test qualification nucleic acid test is Xiamen City, one of the viral nucleic acid test designated institutions.

New Open Source: New Open Source in the medical field currently fully owns Wuhan Heer, Changsha Sanji and Shanghai Jingneng three subsidiaries, and at the same time is merging and acquiring several domestic and foreign medical companies, the business is mainly involved in women's health (cervical cancer, breast cancer diagnosis and treatment), precision medicine (molecular diagnostics, genetic testing).

Changhong Technology: reaction cup products and new coronavirus detection kits (such as gene chips and kit products).

Runda Medical: Shanghai Runda Rongjia, the controlling subsidiary of Runda Medical, based on its IVD scientific research and clinical advantages, and R&D partners Beijing Najie and Hangzhou Pilot to carry out the research and development of two new coronavirus testing products; the kit developed in cooperation with Beijing Najie is equipped with virus inactivation and preservation solution, which can be added directly to the PCR reaction solution for on-line testing, without the need for accounting for the extraction of the test, and it can be tested for 96 samples, 80-80% after adding samples, and it can be tested for 80-80% after adding samples. It can detect 96 samples at a time and produce a report in 80-100 minutes after adding samples; the kit developed in cooperation with Hangzhou Pilot Genetics is equipped with virus inactivation and preservation solution, and the samples can be added directly into the digital PCR reaction solution for on-line detection after nucleic acid extraction, and the report can be produced within 160 minutes.

Huachang Chemical: the company's participation in the investment of Suzhou Ruihua Investment Partnership (the company holds 10% of the fund share) shareholding of Nanjing Shiho gene, practice medicine has successfully developed a new coronavirus nucleic acid test kit.